Society for Immunotherapy of Cancer (SITC) shared on LinkedIn:
“Join Session 203:
Hot Topic Symposium at Society for Immunotherapy of Cancer 26 to explore emerging insights into the factors influencing treatment response and what they could mean for the future of cancer immunotherapy.”
You can also read: The Big Questions in Cancer Immunotherapy: Can We Treat Toxicity Without Losing Antitumor Immunity?
